Dupuytren’s Disease Market to Grow with a CAGR of 4.31% through 2028
The growing shift towards personalized
medicine and rising awareness of Dupuytren’s Disease are the major drivers for
the Global Dupuytren’s Disease Market.
According
to TechSci Research report, “Dupuytren’s Disease Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, the
Global Dupuytren’s Disease Market at USD 4.23 billion in 2022 and is
anticipated to project robust growth in the forecast period with a CAGR of 4.31%
through 2028. This is on account of increasing prevalence of cancer among the
population along with rise in awareness for cancer drugs in the market.
Dupuytren's
disease, a progressive hand ailment that has historically posed challenges for
patients and medical professionals alike. However, a surge in research and
innovation has ushered in a new era of treatment possibilities, igniting a
remarkable surge in demand within the Dupuytren's disease market. Dupuytren's
disease, colloquially referred to as Dupuytren's contracture, is a complex
condition that affects the connective tissue beneath the skin of the palm and
fingers. Characterized by the formation of fibrous cords, it leads to the
gradual bending of the fingers toward the palm, impeding hand function and
quality of life.
The
causes of this ailment are multifaceted, involving genetic predisposition, age,
gender, and lifestyle factors. For years, surgical interventions were the
mainstay of treatment for severe cases of Dupuytren's disease, involving the
removal of the abnormally contracting tissue. However, a new dawn has emerged
with advancements in medical science, offering a range of treatments that cater
to varying stages of the disease and patient preferences. Within the realm of
surgical interventions, advancements have transformed the landscape. Minimally
invasive surgical techniques have gained prominence, offering reduced scarring,
faster recovery times, and enhanced patient outcomes.
Procedures
such as percutaneous needle fasciotomy involve using a needle to divide the
contracted tissue, preserving healthy tissue and minimizing trauma. These
techniques offer a balance between surgical intervention and patient comfort,
contributing to the demand for Dupuytren's disease treatment. Moreover, the
journey of Dupuytren's disease treatment doesn't end with medical
interventions. The realm of rehabilitation and post-treatment care has also
witnessed innovation. Physiotherapy and hand therapy programs have evolved to
encompass cutting-edge techniques that aid in restoring finger mobility,
reducing pain, and enhancing overall hand function.
This
holistic approach to treatment ensures that patients receive comprehensive care
throughout their journey, from diagnosis to recovery. Economic considerations
have also contributed to the expansion of the Dupuytren's disease market. With
the rise in healthcare expenditure and access to medical services, more
patients can afford and seek treatment for their condition. Additionally,
improvements in healthcare infrastructure in developing countries have led to
greater accessibility to treatments that were once limited to affluent nations.
The global economic burden of Dupuytren's disease, particularly in terms of
healthcare costs and lost productivity, has driven healthcare systems and
policymakers to focus on efficient and cost-effective treatment approaches.
This
has spurred innovation and competition within the market, leading to the
development of treatments that are not only effective but also economically
viable. The shift towards a patient-centric approach in healthcare has played a
pivotal role in shaping the Dupuytren's disease market. With patients becoming
more empowered and involved in their healthcare decisions, there is an
increased demand for treatments that not only address the physical symptoms but
also cater to the patient's quality of life and preferences. This demand has
led to a more holistic approach to treatment, where patient comfort,
convenience, and long-term outcomes are considered.
Medical
professionals and pharmaceutical companies are working collaboratively to
design treatments that align with patients' needs and preferences, thereby
enhancing treatment adherence and overall satisfaction. The confluence of
rising prevalence and heightened awareness has spurred increased research into
Dupuytren's disease. Efforts are directed toward unraveling the genetic,
molecular, and environmental factors that contribute to its development. A
deeper understanding of the underlying mechanisms holds the potential to unlock
new treatment avenues, from gene therapies to targeted drug interventions.
Treatment options for Dupuytren's disease have also expanded, thanks to
advancements in medical science. Beyond surgical excision, a spectrum of
interventions now exists, catering to varying disease severity and patient
preferences. From enzyme-based treatments that dissolve the contracting tissue
to needle aponeurotomy, which manually releases the cords, patients have an
array of choices to consider.
Browse
over XX market data Figures and spread through xxx Pages and an in-depth TOC
on "Global Dupuytren’s Disease Market.”
The Global Dupuytren’s Disease Market segmentation
is based disease type, type, company, and Region.
Some
of the major companies operating in the Global Dupuytren’s Disease Market
include:
- Novartis AG
- Pfizer Inc.
- Bayer AG
- Nantong
Jinghua Pharmaceutical Co., Ltd
- Actiza
Pharmaceutical Private Limited
- Endo
International plc
- Spear
Pharmaceuticals
- Hikma
Pharmaceuticals PLC
- Bristol-Myers
Squibb
- Glaxosmithkline
PLC
Download
Free Sample Report
Customers can also request for 10% free
customization on this report.
“Certain regions, particularly Europe, are
projected to exert significant demand for Dupuytren’s Disease Market worldwide.
Europe's Dupuytren's Disease Market is, driven by the escalating prevalence of
the condition within the region. As the population continues to age and
demographics shift, the incidence of Dupuytren's disease is on the rise.
Additionally, advanced healthcare framework ensures that individuals affected
by Dupuytren's disease have access to a wide array of medical services, ranging
from early diagnosis to advanced treatments. The seamless integration of
specialized care within these systems facilitates timely and effective
management of the condition.," said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based Global management consulting firm.
“Dupuytren’s
Disease Market - Global Industry Size,
Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type
(Diagnosis {Physical Examination, X-ray}, Treatment {Surgery, Radiation
Therapy, Needle Aponeurotomy, Steroid Shot, Enzyme Injection, Occupational
Therapy, Others}), By Disease Type (Type I, Type II, Type III), By End-use
(Hospitals, Clinics, Academic & Research Institute, Others), By Region, Competition” has
evaluated the future growth potential of Global Dupuytren’s Disease Market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide innovative market intelligence and help decision makers take
sound investment decisions. Besides, the report also identifies and analyzes
the emerging trends along with essential drivers, challenges, and opportunities
in Global Dupuytren’s Disease Market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com